Clinical Trial Detail

NCT ID NCT01409174
Title IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

melanoma

Therapies

Cisplatin

Ipilimumab

Aldesleukin

Temozolomide

Interferon alpha-2b

Age Groups: adult

No variant requirements are available.